Home > Clinical Trials

Saved trials

Completed
NCT01641510
PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants
70 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Acute Coronary Syndromes
Completed
NCT01703351
Prospective Randomized Trial Comparing the Effectiveness of Continuous Paravertebral Infusion of Local Anesthetics Versus Intravenous Patient-controlled Analgesia on Acute and Chronic Neuropathic Pain After VATS Lobectomy
79 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
Lung Neoplasms
Postoperative Pain
Terminated
NCT02373462
Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF)
1 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Peripheral Artery Disease With Intermittent Claudication
Completed
NCT01872845
A Trial Comparing the Effect of Pravastatin and Rosuvastatin on Atherosclerosis Progression Measured by Carotid Intima Media Thickness in Patients With Coronary Artery Disease After Biolimus Eluting Stent (Nobori®) Implantation: CPR IMT
671 Enrollment(s)
1 Study location(s)
Interventional (Not Applicable)
Coronary Artery Occlusive Disease
Unknown status
NCT02317198
Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly
1,011 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Non-ST-elevation Acute Coronary Syndrome
Unstable Angina
Non-ST-elevation Myocardial Infarction
Completed
NCT00902538
Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension
2,204 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT00923091
Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension
2,689 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT00430950
Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
1,011 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Essential Hypertension